UW's vaccine development company has listed on Nasdaq, with its shares rising on the first day of trading.

Icosavax, a US-based vaccine developer spun out of University of Washington (UW), floated in a $182m initial public offering on Thursday on the Nasdaq Global Select Market. The company issued some 12 million shares having priced them in the middle of the IPO’s $14 to $16 range. They opened at $29 each before closing at…

The rest of this content is only accessible to University Venturing: News, Data, and Events - Global University Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.